<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04098510</url>
  </required_header>
  <id_info>
    <org_study_id>MitoQ</org_study_id>
    <nct_id>NCT04098510</nct_id>
  </id_info>
  <brief_title>Concentration of MitoQ in Human Skeletal Muscle</brief_title>
  <acronym>MitoQ/muscle</acronym>
  <official_title>Concentration of Mitoquinone Mesylate in Skeletal Muscle After a Single Oral Dose of MitoQ</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine mitoquinone mesylate concentration levels in
      skeletal muscle samples obtained after intake of an acute oral dose of MitoQ.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle mitoquinone mesylate concentration</measure>
    <time_frame>Before oral administration of MitoQ</time_frame>
    <description>Concentration of mitoquinone mesylate in skeletal muscle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle mitoquinone mesylate concentration</measure>
    <time_frame>1 hours after oral administration of MitoQ</time_frame>
    <description>Concentration of mitoquinone mesylate in skeletal muscle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle mitoquinone mesylate concentration</measure>
    <time_frame>3 hours after oral administration of MitoQ</time_frame>
    <description>Concentration of mitoquinone mesylate in skeletal muscle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle mitoquinone mesylate concentration</measure>
    <time_frame>5 hours after oral administration of MitoQ</time_frame>
    <description>Concentration of mitoquinone mesylate in skeletal muscle</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood mitoquinone mesylate concentration</measure>
    <time_frame>Before as well as 0.5, 1, 1.5, 2, 3, 4 and 5 hours after oral administration of MitoQ</time_frame>
    <description>Concentration of mitoquinone mesylate in venous blood</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>MitoQ</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects ingest 160 mg of MitoQ</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>MitoQ</intervention_name>
    <description>Subjects ingest 8x20 mg MitoQ capsules</description>
    <arm_group_label>MitoQ</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy,

          -  Male

          -  18-40 years of age

        Exclusion Criteria:

          -  Previous use of MitoQ or CoQ-10 within 30 days of screening appointment

          -  Ongoing use of MitoQ

          -  Smoking

          -  Ongoing treatment with medications

          -  Disease deemed by the MD to infer a risk to participate in the trial
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>August Krogh Building</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morten Hostrup, PhD</last_name>
      <phone>+4524474785</phone>
      <email>mhostrup@nexs.ku.dk</email>
    </contact>
    <investigator>
      <last_name>Matteo Fiorenza, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 18, 2019</study_first_submitted>
  <study_first_submitted_qc>September 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2019</study_first_posted>
  <last_update_submitted>September 20, 2019</last_update_submitted>
  <last_update_submitted_qc>September 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Morten Hostrup, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Mitochondria-targeted antioxidant</keyword>
  <keyword>Skeletal muscle biopsies</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

